The Medspa Red Flag List: What to Notice Before Anyone Touches Your Face

Why a checklist beats a warning

There is a genre of article that treats every medspa as a hazard, and it does not help anyone. The category is large, growing, and contains a great many well-run practices staffed by careful people who take consent, keep proper records and turn patients away when a treatment is not appropriate.

Which means the useful question is not whether to walk in. It is how to tell, in the twenty minutes before anyone touches you, which kind of place you are standing in.

The good news is that the difference is unusually observable. Well-run clinics and volume shops diverge on concrete, checkable things: how the product is stored and opened, whether anyone asks what medications you take, what is in the refrigerator, whether the consult includes the word no, and how fluently someone answers a direct question about complications. None of it requires medical knowledge to notice. It requires knowing what to look at.

What follows is that list, in roughly the order you will encounter it — plus the green flags, because knowing what good looks like is more useful than a catalogue of fears.

Pricing: work out which corner is being cut

Botulinum toxin and hyaluronic acid filler have a real acquisition cost from the manufacturer, which does not vary much between clinics. Add premises, staff, insurance and clinical time, and a floor emerges below which the arithmetic stops working.

So when a price sits meaningfully below that floor — the flash sale, the group-buying voucher, the introductory offer that undercuts everyone — the correct response is not suspicion in the abstract but a specific question: which input is being economised? There are only a few candidates. The product may be diluted beyond normal reconstitution. It may have been acquired outside authorised distribution channels. The person injecting may be cheaper than a licensed injector should be. Or the model may be volume — appointments compressed until there is no time for a history, a consent conversation or a follow-up.

Any of those may be happening, and none of them is visible in the price itself. What is visible is how the price is structured.

Ask for pricing per unit of toxin, and ask which product by brand name. A clinic quoting per unit is telling you something checkable, and you can compare what you received against what you were charged. A clinic quoting per area or per treatment — 'forehead', 'full face' — has removed your ability to know how much product went in. That is not automatically dishonest, and some practices price that way for simplicity. But it is an information asymmetry that favours them, and the request to itemise is entirely reasonable.

One further flag on the commercial side: pressure. Course packages sold before a first treatment, a discount that expires if you leave the building, or a consultation that concludes with a bigger plan than you arrived asking for. Aesthetic medicine is elective, and there is never a clinical reason to decide today.

Provenance: the sealed vial test, and what happened in 2024

This is the flag with the clearest evidence behind it, and it is the one to be most rigid about.

You should be able to see the product. A sealed, labelled vial or a sealed, labelled syringe, opened or reconstituted in front of you, with the box available if you ask. That is the norm in a well-run practice and nobody will be offended by the request.

What should end the appointment is a pre-drawn syringe — product already loaded, sitting in a tray, with no packaging in sight. You cannot know what is in it, at what dilution, how long it has been out of refrigeration, or whether it is the brand you are being charged for. There is no benign version of this that outweighs the risk, and 'we prepare in advance to save time' is a workflow preference, not a justification.

In spring 2024 this stopped being hypothetical. CDC, the FDA and state and local partners investigated clusters of 22 people across 11 states reporting adverse effects after injections with counterfeit botulinum toxin, or injections administered by unlicensed or untrained individuals, or given in non-healthcare settings. Nine people were hospitalised. Four were treated with botulism antitoxin, because their symptoms were consistent with toxin spreading beyond the injection site — blurred or double vision, difficulty swallowing, dry mouth, weakness, shortness of breath, difficulty lifting the head.

Some of the implicated product had been purchased through large online marketplaces rather than through authorised suppliers of FDA-approved products. A separate field report described cases in Tennessee and New York City following administration of presumed counterfeit botulinum toxin in nonmedical settings. And this is not new: a case series published in JAMA in 2006 described botulism in four adults after cosmetic injection with an unlicensed, highly concentrated botulinum preparation.

The pattern across two decades is consistent. The harm concentrates where product provenance is uncertain and where the setting is not a medical one. Both are things you can check by looking.

The intake test

Before any injectable, someone should ask you questions, and the absence of that conversation is a red flag that costs nothing to spot.

A proper history covers medications — anticoagulants and antiplatelet drugs raise bruising risk and change the conversation; some clinicians will ask about supplements for the same reason. It covers allergies and prior reactions, including to previous injectables and to lidocaine, which many fillers contain. It covers autoimmune and neuromuscular conditions, which matter specifically for botulinum toxin. It covers pregnancy and breastfeeding. It covers active infection anywhere near the treatment area, and recent or upcoming dental work, which is relevant to filler complications. And it covers what you have had before and where, because previous filler in a region changes the anatomy and the plan.

If nobody asks any of that, nobody has screened you for a contraindication. That is the point — not that any single question is decisive, but that their total absence tells you the visit is a transaction rather than a consultation.

Two things should follow the history. Consent that names complications specifically rather than gesturing at 'risks', including the vascular ones, and gives you time to read it rather than a clipboard at the door. And baseline photographs, taken at standardised angles and lighting — which protect you as much as the clinic, because they are the only way to settle a later disagreement about what changed. A practice that photographs properly is also a practice whose own marketing images can be assessed; ↗our answer on judging before-and-after photos covers the lighting and angle tells worth knowing.

Our derm visit prep tool will help you arrive with your medication list and questions already written down, which makes the gap conspicuous if nobody asks for them.

What is in the fridge

One question, asked plainly: if I have a vascular occlusion this afternoon, what happens?

The answer you want is fluent and specific. That they would recognise it from pain out of proportion, blanching, and dusky mottling. That hyaluronidase — the enzyme that dissolves hyaluronic acid filler — is on the premises, in useful quantity rather than a single token vial. That somebody authorised to administer it is here now. And that there is a physician reachable who can escalate.

The answers that should concern you are a blank look, a reassurance that it has never happened, or a plan that consists of sending you to an emergency department. The last one sounds responsible and is the weakest of the three, because a general emergency department is not typically stocked with hyaluronidase and its staff will not routinely have managed filler occlusion. The window for this is short. Transferring you spends it.

Ask this even if you are only having toxin, and even if you have had filler somewhere ten times without incident. You are not asking because you expect a complication. You are asking because the answer tells you whether anyone in the building has thought seriously about the day it happens — and a practice that has rehearsed it answers immediately, while a practice that has not will assemble the answer in front of you.

The credential question sits underneath this one, and it is worth understanding separately: who is legally responsible, who supervises, and whether that supervision is physical or a signature on a contract.

Green flags, because knowing what good looks like is the point

The failure of most safety checklists is that they teach you to be afraid rather than to recognise competence. So here is the other list — the things well-run practices do consistently, none of which is expensive or difficult, all of which are observable.

They take an unhurried history and they write it down. They open the product in front of you. They quote per unit and by name. They photograph you at baseline before anything happens. They give you a written aftercare sheet with a phone number that works outside office hours, and they mean it. They offer a follow-up appointment as part of the treatment rather than as a separate purchase, because reviewing a result at two weeks is how you learn whether the dosing was right.

And the strongest signal of all: they tell you what a treatment cannot do, and sometimes they decline. A practitioner who says a filler will not fix that particular concern, or that you should wait, or that what you are describing needs a dermatologist rather than an aesthetic treatment, is demonstrating the thing that cannot be faked — a willingness to lose the sale. ↗Our answer on what to ask before any cosmetic procedure sets out the broader version of that conversation.

Three things should end a visit outright. Pre-drawn syringes with no packaging. Nobody taking a medical history. And a blank look at the occlusion question.

Afterwards, keep the routine simple for a few days and follow your injector's instructions over anything you read. A mild cleanser such as La Roche-Posay Toleriane Hydrating Gentle Cleanser, a plain moisturiser like La Roche-Posay Toleriane Ultra Sensitive, and sun protection such as Vanicream Mineral Sunscreen over any bruising, since ultraviolet exposure on resolving bruising can leave pigmentation that outlasts the bruise by months. A hydrating serum like CeraVe Hydrating Hyaluronic Acid Serum is fine, with one clarification worth making because the shared name misleads constantly: topical ↗hyaluronic acid is a humectant sitting on the surface of your skin, and it has no relationship to the cross-linked gel in a filler syringe. Skip retinoids and acids until your injector says otherwise, and treat any pain that is escalating rather than settling as a reason to call the clinic immediately rather than wait until morning.